"Correct understanding of diseases / disorders mechanisms is the first objective. Finding the most adapted integrated diagnostics, therapies & preventive solutions are the necessary consequences of the first objective".
Bio-Modeling Systems is the world’s first Mechanisms-Based Medicine company that changed the discovery paradigm to create novel robust medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADI™* models.
We propose to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses.
Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed in Pharma, Biotech, Cosmetics, Nutrition and digital-Health, CADI™ Discovery capability to achieve:
A world's first in neurodegenerative diseases (publication) with CEA: 2 awards in the US & Europe.
Pherecydes-Pharma: BMSystems' spin-off, MR infections therapies, 3 patents, publication, world's first multi-centric clinical trial with bacteriophages in Phase I/II, Compassionate Use Success.
CEA/BMSystems collaborative research in CNS that led to the co-owned patent WO201029131 with a worldwide exclusive license to Theranexus, CEA’s spin-off currently in Phase II, and
We warmly invite you to download our management summary, our Short corporate Presentation or our CADI™ Discovery Concept and POCs Presentation.
The life-modeling issue: Are we using the right concepts in the righ order?
CADI™ : Computer Assisted Deductive Integration Rational